United States Bioprocess Market Insight
Published: 15 June 2026 | Report Format: Electronic (PDF)
The United States Bioprocess Market is projected to grow at a CAGR of around 10.2%, driven by increasing biologics production, rising cell and gene therapy commercialization, expansion of biomanufacturing facilities, adoption of single-use technologies, and growing investments in advanced bioprocessing solutions.
United States Bioprocess Market Forecasts to 2035
- The United States Bioprocess Market Size Was Estimated at USD 24.8 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 10.2% from 2025 to 2035.
- The United States Bioprocess Market Size is Expected to Reach around USD 65.8 Billion by 2035.
Notable Insights for the United States Bioprocess Market
- Segmentation Based on Product Type, single-use bioprocessing systems held a dominant position in 2025 with nearly 42% share, supported by reduced contamination risks, lower capital expenditure requirements, and enhanced manufacturing flexibility.
- Segmentation Based on Application, biologics manufacturing accounted for approximately 58% share in 2025, driven by increasing monoclonal antibody production, biosimilar development activities, and expanding commercial-scale biopharmaceutical operations.
- The market is led by Thermo Fisher Scientific Inc., Danaher Corporation, and Sartorius AG; Thermo Fisher Scientific reported approximately USD 43.22 billion revenue in FY2025, strengthening its leadership across bioprocessing technologies and services.
- Danaher Corporation generated approximately USD 24.15 billion revenue in FY2025, while Sartorius AG reported nearly USD 4.10 billion revenue, highlighting the strong financial position of major global bioprocess solution providers.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United States Bioprocess Market
This study employs a combination of primary and secondary research methodologies to analyze the United States Bioprocess Market. Primary research includes interviews and discussions with bioprocess equipment manufacturers, biopharmaceutical companies, contract manufacturing organizations, raw material suppliers, research institutions, industry experts, and key stakeholders. Secondary research involves company annual reports, regulatory publications, government databases, scientific journals, investor presentations, industry white papers, and market intelligence sources. Market estimations are derived using both top-down and bottom-up approaches, while data triangulation and validation techniques ensure the accuracy and reliability of market forecasts, competitive assessments, and industry trends.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States bioprocess market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Bioprocess Market
- Thermo Fisher Scientific Inc.
- Danaher Corporation (Cytiva)
- Sartorius AG
- Merck KGaA
- Repligen Corporation
- Eppendorf SE
- Avantor Inc.
- Corning Incorporated
- Getinge AB
- Parker Hannifin Corporation
Recent Developments:
- In October 2025, Thermo Fisher Scientific Inc. launched an advanced single-use bioreactor platform designed to improve process scalability, operational efficiency, and biologics manufacturing productivity across commercial bioprocessing facilities.
- In August 2025, Sartorius AG collaborated with a leading U.S. biopharmaceutical manufacturer to accelerate next-generation bioprocess development through integrated automation, analytics, and intensified manufacturing technologies.
Market Segmentation:
United States Bioprocess Market, By Product Type
- Single-Use Bioprocessing Systems
- Bioreactors
- Filtration Systems
- Cell Culture Media
- Chromatography Systems
- Consumables & Accessories
- Others
United States Bioprocess Market, By Workflow
- Upstream Processing
- Downstream Processing
United States Bioprocess Market, By Application
- Biologics Manufacturing
- Vaccine Production
- Cell & Gene Therapy Manufacturing
- Biosimilar Production
- Research & Development
- Others
United States Bioprocess Market, By End User
- Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Others
United States Bioprocess Market, By Technology
- Single-Use Technology
- Stainless Steel Technology
- Hybrid Systems
Expert Views:
The United States Bioprocess Market is expected to witness strong growth through 2035, supported by expanding biologics pipelines, increasing investment in biomanufacturing infrastructure, rising adoption of single-use technologies, and continued product launches and collaborations among leading market participants, enhancing industry competitiveness and long-term market expansion.
Author: Komal and Radhika By Decisions Advisors and Consulting